Psychiatric disorders and following risk of chronic kidney disease: a prospective cohort study from UK Biobank

被引:1
作者
Li, Hanfei [1 ,2 ,3 ]
Li, Chunyang [1 ,2 ,4 ]
Zhang, Chao [1 ,2 ,4 ]
Ying, Zhiye [1 ,2 ,4 ]
Wu, Chuanfang [3 ]
Zeng, Xiaoxi [1 ,2 ,4 ]
Bao, Jinku [3 ]
机构
[1] Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu 610041, Peoples R China
[3] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China
[4] Sichuan Univ, Med X Ctr Informat, Chengdu 610065, Peoples R China
基金
英国科研创新办公室;
关键词
Psychiatric disorders; Chronic kidney diseases; Age as time scale; Mediation analysis; DEPRESSIVE SYMPTOMS; ASSOCIATION; ADULTS; HYPERTENSION; PREVALENCE; DIAGNOSIS; SURVIVAL; ANXIETY; STROKE;
D O I
10.1186/s12888-024-06461-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundPsychiatric disorders have been reported to influence many health outcomes, but evidence about their impact on chronic kidney disease (CKD) has not been fully explored, as well as possible mechanisms implicated are still unclear. MethodsFour hundred forty-one thousand eight hundred ninety-three participants from UK Biobank were included in this study. To assess the association between psychiatric disorders mainly including depression, anxiety, stress-related disorders, substance misuse as well as psychotic disorder, and CKD, a Cox regression model using age as the underlying time scale was employed. This approach considers the age progression of participants from the beginning to the end of the study as the elapsed time. Flexible nonparametric smoothing model was conducted to illustrate the temporal patterns. Subgroup analyses were performed by stratification of gender, genetic susceptibility to CKD, age at entry or exit the cohort, follow-up duration, and the number of psychiatric disorders at baseline. Mediation analysis was implemented to evaluate the roles of body mass index (BMI), hypertension, and diabetes. ResultsCompared with individuals without psychiatric disorders, an increased risk of CKD was observed in patients with psychiatric disorders (hazard ratios (HR) = 1.52, 95% confidence intervals (CI): 1.40-1.65, p-value < 0.001). The hazard ratio among psychiatric patients gradually increased, and became significant after about 10 years follow-ups. The HR for patients followed up for 10-12 years was 1.60 (95% CI: 1.34-1.91, p-value < 0.001), and the HR was 1.66 (95% CI: 1.29-2.13, p-value < 0.001) for patients followed up for 12-13 years. Five distinct psychiatric disorders were found to be significantly associated with an increased risk of developing CKD. The highest HR was observed between stress-related disorder and CKD (HR = 1.95, 95%CI: 1.28-2.97, p-value = 0.002). When adjusting genetic susceptibility to CKD, the HR for the association between stress-related disorders and CKD became 1.86 (95%CI: 1.14-3.04, p-value = 0.013). Although these associations were nominally significant, they did not reach statistical significance after applying the Bonferroni multiple corrections, potentially due to the limited sample size. Subgroup analysis revealed that psychiatric patients who are under age 60, with multiple psychiatric morbidities or having been diagnosed with psychiatric disorders for over 10 years may be high-risk populations. Hypertension, BMI and diabetes mediated 49.13% (95% CI: 37.60%-67.08%), 12.11% (95% CI: 8.49%-17.24%) and 3.78% (95% CI: 1.58%-6.52%) of the total effect, respectively. ConclusionsPsychiatric disorders were associated with a delayed onset of an elevated risk for CKD, this association was only observed in patients with psychiatric disorders for more than 10 years. Our study highlights the significance of lifestyle interventions, routine monitoring of kidney function, early screening for CKD, and personalized management strategies for psychiatric patients as potential approaches to the precise prevention of CKD.
引用
收藏
页数:14
相关论文
共 70 条
[1]   The prevalence of comorbid depression in adults with diabetes - A meta-analysis [J].
Anderson, RJ ;
Freedland, KE ;
Clouse, RE ;
Lustman, PJ .
DIABETES CARE, 2001, 24 (06) :1069-1078
[2]   Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Bikbov, Boris ;
Purcell, Carrie ;
Levey, Andrew S. ;
Smith, Mari ;
Abdoli, Amir ;
Abebe, Molla ;
Adebayo, Oladimeji M. ;
Afarideh, Mohsen ;
Agarwal, Sanjay Kumar ;
Agudelo-Botero, Marcela ;
Ahmadian, Elham ;
Al-Aly, Ziyad ;
Alipour, Vahid ;
Almasi-Hashiani, Amir ;
Al-Raddadi, Rajaa M. ;
Alvis-Guzman, Nelson ;
Amini, Saeed ;
Andrei, Tudorel ;
Andrei, Catalina Liliana ;
Andualem, Zewudu ;
Anjomshoa, Mina ;
Arabloo, Jalal ;
Ashagre, Alebachew Fasil ;
Asmelash, Daniel ;
Ataro, Zerihun ;
Atout, Maha Moh'd Wahbi ;
Ayanore, Martin Amogre ;
Badawi, Alaa ;
Bakhtiari, Ahad ;
Ballew, Shoshana H. ;
Balouchi, Abbas ;
Banach, Maciej ;
Barquera, Simon ;
Basu, Sanjay ;
Bayih, Mulat Tirfie ;
Bedi, Neeraj ;
Bello, Aminu K. ;
Bensenor, Isabela M. ;
Bijani, Ali ;
Boloor, Archith ;
Borzi, Antonio M. ;
Camera, Luis Alberto ;
Carrero, Juan J. ;
Carvalho, Felix ;
Castro, Franz ;
Catala-Lopez, Ferran ;
Chang, Alex R. ;
Chin, Ken Lee ;
Chung, Sheng-Chia ;
Cirillo, Massimo .
LANCET, 2020, 395 (10225) :709-733
[3]   Chronic kidney disease in adults with schizophrenia: A nationwide population-based study [J].
Bitan, Dana Tzur ;
Krieger, Israel ;
Berkovitch, Anat ;
Comaneshter, Doron ;
Cohen, Arnon .
GENERAL HOSPITAL PSYCHIATRY, 2019, 58 :1-6
[4]   Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function [J].
Brennan, Eoin ;
Kantharidis, Phillip ;
Cooper, Mark E. ;
Godson, Catherine .
NATURE REVIEWS NEPHROLOGY, 2021, 17 (11) :725-739
[5]   Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease [J].
Burnier, Michel ;
Damianaki, Aikaterini .
CIRCULATION RESEARCH, 2023, 132 (08) :1050-1063
[6]   Chronic kidney disease and severe mental illness: a scoping review [J].
Carswell, Claire ;
Cogley, Clodagh ;
Bramham, Kate ;
Chilcot, Joseph ;
Noble, Helen ;
Siddiqi, Najma .
JOURNAL OF NEPHROLOGY, 2023, 36 (06) :1519-1547
[7]   Social deprivation and survival on renal replacement therapy in England and Wales [J].
Caskey, F. J. ;
Roderick, P. ;
Steenkamp, R. ;
Nitsch, D. ;
Thomas, K. ;
Ansell, D. ;
Feest, T. .
KIDNEY INTERNATIONAL, 2006, 70 (12) :2134-2140
[8]   Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040 [J].
Chen, Jing ;
Li, Chunyang ;
Bu, Ci Li Nong ;
Wang, Yujiao ;
Qi, Mei ;
Fu, Ping ;
Zeng, Xiaoxi .
CHINESE MEDICAL JOURNAL, 2025, 138 (11) :1334-1344
[9]   Chronic Kidney Disease Diagnosis and Management: A Review [J].
Chen, Teresa K. ;
Knicely, Daphne H. ;
Grams, Morgan E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (13) :1294-1304
[10]   Obesity Management and Chronic Kidney Disease [J].
Chen, Yang ;
Dabbas, Walaa ;
Gangemi, Antonio ;
Benedetti, Enrico ;
Lash, James ;
Finn, Patricia W. ;
Perkins, David L. .
SEMINARS IN NEPHROLOGY, 2021, 41 (04) :392-402